| Males | Females | ||
---|---|---|---|---|
 | <100 m | 100-250 m | <100 m | 100-250 m |
Persistent wheeze | 1.76 * (1.08-2.87) | 1.54 # (0.94-2.53) | 1.32 (0.76-2.28) | 0.77 (0.42-1.42) |
Dyspnea | 0.88 (0.55-1.41) | 0.86 (0.59-1.53) | 1.61 ** (1.13-2.27) | 1.35 # (0.95-1.93) |
COPD | 1.80 * (1.03-3.08) | 1.21 (0.69-2.13) | 1.60 (0.71-3.59) | 0.99 (0.39-2.51) |
Asthma | 1.59 (0.85-2.98) | 1.55 (0.83-2.87) | 1.68 # (0.97-2.88) | 0.58 (0.30-1.15) |
Attacks of shortness of breath with wheeze | 1.47 (0.87-2.48) | 1.20 (0.70-2.04) | 1.67 # (0.98-2.84) | 0.74 (0.39-1.38) |
Skin test_5 mm pos. | 1.07 (0.67-1.72) | 1.10 (0.70-1.73) | 1.83 * (1.11-3.00) | 0.95 (0.57-1.60) |
FEV1/FVC% <70% | 2.07 * (1.11-3.87) | 2.53 ** (1.42-4.53) | 1.01 (0.48-2.14) | 0.88 (0.41-1.89) |
FEV1/VC% <70% | 1.15 (0.63-2.11) | 1.76 * (1.02-3.04) | 0.84 (0.40-1.72) | 0.48 (0.21-1.11) |